Latest News

All Articles

Filter by:
Topic
Digital medical illustration of a bladder
Tools and Resources Drug Updates

Pharmacist's Application
to Practice: Nogapendekin
alfa inbakicept-pmln

August 27, 2024

Devan Parker, PharmD, PGY2 Oncology Pharmacy Resident and Juliana Leedy, PharmD, MS, Clinical Oncology Pharmacist, The University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama writes about nogapendekin alfa inbakicept-pmln.

LED sign that reads CAR T Cells
HOPA News Late Breaking News

Late-Breaking HOPA News: CAR-T Approval Updates

July 22, 2024

CAR-T approval updates show the treatment moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia

Early-Stage Non-small Cell Lung Cancer

Late-Breaking HOPA News: Adjuvant Alectinib in Early-Stage Non-small Cell Lung Cancer (NSCLC)

June 12, 2024

In April 2024, the FDA approved alectinib (Alecensa®) in patients with early-stage ALK-positive non-small cell lung cancer (NSCLC) based on the ALINA trial.

Collaborations BCOP

HOPA Curated BCOP CE Program (Part of Oncology Pharmacists Connect)

June 04, 2024

HOPA's BCOP Program presents highly sought after education at an affordable price. Join us following the Oncology Pharmacists Connect!

Pharmacist’s Application to Practice: Tislelizumab-jsgr

May 21, 2024

Kristine Pisikian, PharmD, PGY-1 Pharmacist Resident and Caroline Quinn, PharmD, BCOP, Specialty Clinical Program Director at Prime Therapeutics write about Tislelizumab-jsgr.

Advocacy

Pharmacists & Patients Lend Their Voices to Virtual Hill Day

May 07, 2024

HOPA members, patients, and caregivers participated in a total of 80 meetings with representatives from 31 states.

Metastatic Colorectal Cancer
Journal Club

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

May 04, 2024

The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously

Jolynn Sessions giving her incoming president's address at HOPA
HOPA Members

HOPA President Committed to Direct Patient Care, Especially for Veterans with Cancer

April 15, 2024

Dr. Sessions has dedicated her career to providing direct patient care, and currently to veterans with cancer.

black and white photo of woman of color receiving IV chemo
HOPA Members

Combating Health Disparities within Indigenous Communities Amid Cancer Treatment

April 15, 2024

Learn how a HOPA Member connects research with his intimate knowledge of health disparities amongst sovereign Indigenous nations across the US.

Tools and Resources

Standardization of IDS Key Performance Indicators and Metrics; Results of a HOPA IDS SIG Survey

April 10, 2024

The Hematology/Oncology Pharmacy Association has helped establish practical guidance for Investigational Services metrics and site utilization.

HOPA Members

HOPA's Conference a Notable Event for Tampa Convention Center

April 05, 2024

Immediate Past President LeAnne Kennedy gave Spectrum News 9 a tour of HOPA2024 at the Tampa Convention Center and talked about being back at the TCC after COVID-19 disrupted HOPA's conference in 2020

medical illustration of inflamation from osteoporosis

Late-Breaking HOPA News: Severe Hypocalcemia in Patients with Advanced Chronic Kidney Disease on Denosumab Therapy

April 01, 2024

Originally approved for the treatment of osteoporosis in postmenopausal women at high risk for fractures, denosumab is now frequently used in the management of hypercalcemia of malignancy and to decrease skeletal-related events for certain cancer patients